RPG Life Sciences Limited has informed the Exchange that Board of Directors at its meeting held on April 28, 2025, recommended Final Dividend of Equity share (250% on the face value of Rs 8 each) and additionally a special dividend of Rs. 4 (Rupees Four only) per equity share (50% on the face value of Rs. 8 each) on account of significant exceptional profit on assignment of land for the financial year 2024-25, subject to the approval of shareholders at the ensuing Annual General Meeting.